|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Feb 1, 2025
|
FY2024
12 months to Feb 3, 2024
|
FY2023
12 months to Jan 28, 2023
|
FY2022
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Restructuring charges | |||||
| Goodwill impairment | |||||
| Goodwill and intangible asset impairments | |||||
| Operating income | |||||
| Other income (expense): | |||||
| Gain (loss) on disposal of subsidiaries, net | |||||
| Investment income and other | |||||
| Interest expense | |||||
| Earnings before income tax expense and equity in income of affiliates | |||||
| Income tax expense | |||||
| Equity in income of affiliates | |||||
| Net earnings | |||||
| Basic earnings per share (in dollars per share) | |||||
| Diluted earnings per share (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
